Detalhe da pesquisa
1.
Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee Report.
J Rheumatol
; 51(2): 150-159, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399462
2.
Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives.
Curr Rheumatol Rep
; 26(5): 178-187, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38372872
3.
2023 ACR/EULAR antiphospholipid syndrome classification criteria.
Ann Rheum Dis
; 82(10): 1258-1270, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640450
4.
A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance.
Rheumatology (Oxford)
; 61(7): 2993-2998, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791113
5.
Manual rotation of occiput posterior or transverse positions: a systematic review and meta-analysis of randomized controlled trials.
Am J Obstet Gynecol
; 226(6): 781-793, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34800396
6.
Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Lupus
; 31(13): 1595-1605, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36112747
7.
Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses.
Lupus
; 31(14): 1816-1823, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36177950
8.
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications.
Lupus
; 30(11): 1799-1807, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34284674
9.
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
Lupus
; 30(14): 2276-2285, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34915764
10.
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
Curr Rheumatol Rep
; 23(8): 65, 2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34218350
11.
E-health education interventions on HbA1c in patients with type 1 diabetes on intensive insulin therapy: A systematic review and meta-analysis of randomized controlled trials.
Diabetes Metab Res Rev
; 36(6): e3313, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32212412
12.
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
Lupus
; 29(11): 1353-1363, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32703117
13.
Health-Related Quality of Life in Antiphospholipid Syndrome: Current Knowledge and Future Perspectives.
Curr Rheumatol Rep
; 22(6): 20, 2020 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32405870
14.
New Insights into the Use of Direct Oral Anticoagulants in Non-high Risk Thrombotic APS Patients: Literature Review and Subgroup Analysis from a Meta-analysis.
Curr Rheumatol Rep
; 22(7): 25, 2020 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436109
15.
Response to: Correspondence on 'ACR/EULAR antiphospholipid syndrome classification criteria' by Damoiseaux and van Beers.
Ann Rheum Dis
; 83(3): e7, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37989544
16.
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Miro-Mur et al.
Ann Rheum Dis
; 83(3): e3, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37989545
17.
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang et al.
Ann Rheum Dis
; 83(3): e5, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37989547
18.
Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?
Curr Rheumatol Rep
; 19(10): 64, 2017 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28871481
19.
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
Curr Rheumatol Rep
; 18(12): 74, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27812956
20.
Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study.
Rheumatology (Oxford)
; 54(11): 2071-5, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26163690